Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series

被引：0
|
作者：
Katsuhisa Ohgi
Yusuke Yamamoto
Teiichi Sugiura
Yukiyasu Okamura
Takaaki Ito
Ryo Ashida
Takeshi Aramaki
Katsuhiko Uesaka
机构：
[1] Shizuoka Cancer Center,Division of Hepato
[2] Shizuoka Cancer Center,Biliary
来源：
Annals of Surgical Oncology | 2017年 / 24卷
关键词：
Venous Involvement; Borderline Resectable Pancreatic Cancer (BRPC); Positive Peritoneal Lavage Cytology; Unresectable Group; Venereal Contact;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2752 / 2761
页数：9
相关论文
共 50 条
  • [21] A logistic regression model to predict long-term survival for borderline resectable pancreatic cancer patients with upfront surgery
    Huang, Jin-Can
    Lyu, Shao-Cheng
    Pan, Bing
    Wang, Han-Xuan
    Ma, You-Wei
    Jiang, Tao
    He, Qiang
    Lang, Ren
    CANCER IMAGING, 2025, 25 (01)
  • [22] Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
    Versteijne, Eva
    van Dam, Jacob L.
    Suker, Mustafa
    Janssen, Quisette P.
    Groothuis, Karin
    Akkermans-Vogelaar, Janine M.
    Besselink, Marc G.
    Bonsing, Bert A.
    Buijsen, Jeroen
    Busch, Olivier R.
    Creemers, Geert-Jan M.
    van Dam, Ronald M.
    Eskens, Ferry A. L. M.
    Festen, Sebastiaan
    de Groot, Jan Willem B.
    Koerkamp, Bas Groot
    de Hingh, Ignace H.
    Homs, Marjolein Y., V
    van Hooft, Jeanin E.
    Kerver, Emile D.
    Luelmo, Saskia A. C.
    Neelis, Karen J.
    Nuyttens, Joost
    Paardekooper, Gabriel M. R. M.
    Patijn, Gijs A.
    van der Sangen, Maurice J. C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    Zwinderman, Aeilko H.
    Punt, Cornelis J.
    van Tienhoven, Geertjan
    van Eijck, Casper H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (11) : 1220 - +
  • [23] Upfront surgery versus neoadjuvant chemotherapy for borderline resectable pancreatic carcinoma with venous encasement more than 180 degree, comparative study
    Khalil, Ahmed
    Sabry, Ahmed Mohamed
    Sherif, Diaa Eldin M.
    Zaid, Mohamed H. H.
    EGYPTIAN JOURNAL OF SURGERY, 2023, 42 (02): : 482 - 487
  • [24] Treatment strategy for borderline resectable pancreatic cancer with artery involvement.
    Hirono, Seiko
    Kawai, Manabu
    Okada, Ken-Ichi
    Miyazawa, Motoki
    Shimizu, Atsushi
    Kitahata, Yuji
    Ueno, Masaki
    Hayami, Shinya
    Yamaguchi, Shunsuke
    Takifuji, Katsunari
    Hotta, Tsukasa
    Nakamura, Masaki
    Matsuda, Kenji
    Yamaue, Hiroki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [25] Borderline Resectable Pancreatic Cancer With Artery Involvement: Preoperative Evaluation and Response
    Hata, S.
    Kuroda, A.
    Hayasaka, M.
    Yamaguchi, H.
    Teruya, M.
    Kaminishi, M.
    PANCREAS, 2019, 48 (10) : 1440 - 1440
  • [26] Treatment Strategy for Borderline Resectable Pancreatic Cancer With Radiographic Artery Involvement
    Hirono, Seiko
    Kawai, Manabu
    Okada, Ken-ichi
    Miyazawa, Motoki
    Shimizu, Atsushi
    Kitahata, Yuji
    Ueno, Masaki
    Yamaue, Hiroki
    PANCREAS, 2016, 45 (10) : 1438 - 1446
  • [27] Adjunctive Superior Mesenteric-Portal Venous Reconstruction in the Treatment of Borderline Resectable Pancreatic Adenocarcinoma
    Duong, William Q.
    Fujitani, Roy
    Tohmasi, Steven
    Kabutey, Nii-Kabu
    Maithel, Shelley
    Farzaneh, Cyrus
    Jutric, Zeljka
    Imagawa, David
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (01) : E68 - E68
  • [28] Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
    Jung, Hye-Sol
    Kim, Hyeong Seok
    Kang, Jae Seung
    Kang, Yoon Hyung
    Sohn, Hee Ju
    Byun, Yoonhyeong
    Han, Youngmin
    Yun, Won-Gun
    Cho, Young Jae
    Lee, Mirang
    Kwon, Wooil
    Jang, Jin-Young
    CANCERS, 2022, 14 (18)
  • [29] Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?
    Fossaert, Violette
    Mimmo, Antonio
    Rhaiem, Rami
    Rached, Linda J.
    Brasseur, Mathilde
    Brugel, Mathias
    Pegoraro, Francesca
    Sanchez, Stephane
    Bouche, Olivier
    Kianmanesh, Reza
    Piardi, Tullio
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] Borderline Resectable Pancreatic Cancer Patients Have Superior Survival Following Neoadjuvant Therapy Compared to Upfront Resectable Patients
    Deig, C.
    Trone, K.
    Beneville, B.
    Stratton, A.
    Liu, A.
    Kanwar, A.
    Grossblatt-Wait, A.
    Sheppard, B.
    Attia, F.
    Bassale, S.
    Chen, Y.
    Keith, D.
    Chen, E.
    Lopez, C.
    Gilbert, E.
    Billingsley, K.
    Nabavizadeh, N.
    Thomas, C. R., Jr.
    Grossberg, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E581 - E582
12345